Question 1

Am I eligible for this trial based on my cancer type and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR). clinical trial (NCT01717807). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the C11-Erlotinib PET/CT imaging help in my treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR). clinical trial (NCT01717807). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential benefits and risks of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR). clinical trial (NCT01717807). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for imaging and follow-up?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR). clinical trial (NCT01717807). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I do not respond to the treatment being studied?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR). clinical trial (NCT01717807). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there other treatment options available if I don't qualify for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR). clinical trial (NCT01717807). Contact the study team or your healthcare provider for specific answers.

What this study is about